Seeing Is Believing
Healthcare - Sector
Zealand Pharma A/S ADR's activity chart (see below) currently has 29 price targets and 22 ratings on display.
Analysts average stock forecasts to be materialized ratio is 66.67% with an average time for these price targets to be met of 130.14 days.
Most recent stock forecast was given by from NEEDHAM on 14-Jul-2022. First documented stock forecast 05-Sep-2017.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Mar-2022
$32
$14.41 (81.92%)
$32
4 years 2 months ago
(14-Jul-2022)
0/5 (0%)
$17.06 (114.19%)
Buy Since 15-Oct-2019
$41
5 years 5 months 21 days ago
(24-Mar-2021)
2/2 (100%)
$13.45 (48.82%)
93
Buy Since 12-Sep-2018
$44
$26.41 (150.14%)
$45
5 years 10 months 1 days ago
(13-Nov-2020)
10/12 (83.33%)
$6.73 (18.06%)
77
Buy Since 05-Sep-2017
$42
$24.41 (138.77%)
$32
6 years 9 months 30 days ago
(15-Nov-2019)
4/4 (100%)
$10.67 (34.06%)
332
What is ZEAL (Zealand Pharma A/S ADR) average time for price targets to be met?
Which analyst most recently updated their price target on ZEAL (Zealand Pharma A/S ADR)?
Which analyst has the most public recommendations on ZEAL (Zealand Pharma A/S ADR)?
Which analyst is the currently most bullish on ZEAL (Zealand Pharma A/S ADR)?
Which analyst is the currently most reserved on ZEAL (Zealand Pharma A/S ADR)?